Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4060
-0.0040 (-0.98%)
At close: Jul 24, 2026
Medicofarma Biotech Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 0.28 | 1.22 | 0.75 | 4.25 | 3.34 | 3.65 | |
Revenue Growth (YoY) | -73.64% | 63.14% | -82.34% | 27.45% | -8.59% | 14.63% |
Cost of Revenue | 3.13 | 3.32 | 3.35 | 5.83 | 3.62 | 4.07 |
Gross Profit | -2.85 | -2.09 | -2.6 | -1.58 | -0.29 | -0.31 |
Other Operating Expenses | -0.02 | -0.02 | 0.88 | -0 | -0.07 | 0.18 |
Total Operating Expenses | -0.02 | -0.02 | 0.88 | -0 | -0.07 | 0.18 |
Operating Income | -2.83 | -2.07 | -3.47 | -1.58 | -0.22 | -0.6 |
Interest Income | - | 0 | 0 | 0 | 0.04 | 0.01 |
Interest Expense | -0.25 | -0.25 | -0.18 | -0.01 | -0.04 | -0.31 |
Total Non-Operating Income (Expense) | -0.25 | -0.25 | -0.18 | -0.01 | 0 | -0.3 |
Pretax Income | -3.08 | -2.32 | -3.65 | -1.59 | -0.22 | -0.9 |
Provision for Income Taxes | -0.02 | -0.02 | -0.21 | 0 | 0 | 0.02 |
Net Income | -3.06 | -2.3 | -3.44 | -1.59 | -0.22 | -0.92 |
Net Income to Common | -3.06 | -2.3 | -3.44 | -1.59 | -0.22 | -0.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 68 | 68 | 68 | 68 | 68 | 7 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 68 | 68 | 7 |
Shares Change (YoY) | - | - | - | - | 900.00% | - |
EPS (Basic) | -0.04 | -0.03 | -0.05 | -0.02 | -0.00 | -0.13 |
EPS (Diluted) | -0.04 | -0.03 | -0.05 | -0.02 | -0.00 | -0.13 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -1.28 | -1.02 | -1.1 | -0.25 | -0.48 | -0.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.02 | -0.01 | -0.02 | -0.00 | -0.01 | -0.05 |
Gross Margin | -1011.93% | -170.76% | -345.98% | -37.09% | -8.57% | -8.45% |
Operating Margin | -1005.43% | -169.34% | -462.58% | -37.07% | -6.54% | -16.32% |
Profit Margin | -1085.52% | -187.82% | -458.07% | -37.38% | -6.45% | -25.09% |
FCF Margin | -455.80% | -83.23% | -146.38% | -5.83% | -14.48% | -8.54% |
EBITDA | -1.28 | -0.53 | -1.48 | 0.17 | 0.73 | -0.56 |
EBITDA Margin | -455.31% | -42.94% | -197.71% | 4.04% | 21.96% | -15.26% |
EBIT | -2.83 | -2.07 | -3.47 | -1.58 | -0.22 | -0.6 |
EBIT Margin | -1005.43% | -169.34% | -462.58% | -37.07% | -6.54% | -16.32% |
Effective Tax Rate | 0.74% | 0.98% | 5.82% | 0.00% | 0.00% | -2.29% |